Valuation : PeptiDream Inc.

Market Cap 141B 914M 786M 739M 675M 1.26B 86.63B 1.27B 8.76B 3.39B 44.28B 3.43B 3.36B P/E 2026 *
13.9x
P/E 2027 * 13.5x
Enterprise Value 111B 721M 620M 584M 533M 994M 68.39B 999M 6.91B 2.68B 34.96B 2.71B 2.65B EV / Sales 2026 *
2.73x
EV / Sales 2027 * 2.36x
Free-Float
72.25%
Yield 2026 *
-
Yield 2027 * 0.36%
1 day+0.05%
1 week+1.95%
Current month+0.60%
1 month+10.51%
3 months+9.49%
6 months-24.82%
Current year-33.81%
1 week 1,056.5
Extreme 1056.5
1,112
1 month 972.5
Extreme 972.5
1,155
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,793
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
4,005
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 2021-12-31
Chief Tech/Sci/R&D Officer - 2024-03-31
Chief Operating Officer - 2026-07-01
Director TitleAgeSince
Director/Board Member 51 2008-07-31
Director/Board Member 51 2017-08-31
Director/Board Member 55 2021-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+1.95%-36.23%-34.34% 907M
+2.02%+1.26%+41.37%+105.18% 67.82B
-0.41%-2.30%+33.53%+78.63% 63.22B
-1.11%+2.78%-14.86%+375.59% 27.58B
-4.92%-3.22%-3.90%-17.87% 26.06B
0.00%+0.12%+30.91%+15.46% 25.38B
+1.12%+0.84%+24.50%-17.84% 19.89B
+6.04%+7.25%+233.25%+383.12% 17.4B
0.00%-1.01%-6.78%+524.84% 14.95B
-2.27%+1.37%+53.01%+160.83% 14.62B
Average +0.05%+1.00%+35.48%+157.36% 27.78B
Weighted average by Cap. +0.17%+0.44%+37.38%+139.90%

Financials

2026 *2027 *
Net sales 40.79B 265M 227M 214M 195M 364M 25.08B 366M 2.54B 981M 12.82B 993M 972M 42.75B 277M 238M 224M 205M 382M 26.28B 384M 2.66B 1.03B 13.43B 1.04B 1.02B
Net income 10.22B 66.25M 56.96M 53.59M 48.91M 91.27M 6.28B 91.74M 635M 246M 3.21B 249M 243M 10.52B 68.22M 58.66M 55.18M 50.36M 93.98M 6.47B 94.46M 654M 253M 3.31B 256M 251M
Net Debt -29.66B -192M -165M -156M -142M -265M -18.24B -266M -1.84B -713M -9.32B -722M -707M -39.87B -259M -222M -209M -191M -356M -24.51B -358M -2.48B -959M -12.53B -971M -950M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
763
Date Price Change Volume
26-09-08 JP¥1,096.50 +0.05% 260,500
26-09-08 JP¥1,096.00 +0.69% 829,800
26-09-07 JP¥1,088.50 +1.82% 544,100
26-09-04 JP¥1,069.00 -2.64% 733,500
26-09-03 JP¥1,098.00 +2.09% 550,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,096.00JPY
Average target price
2,725.00JPY
Spread / Average Target
+148.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!